Literature DB >> 16412660

Effect of tempol on altered angiotensin II and acetylcholine-mediated vascular responses in thoracic aorta isolated from rats with insulin resistance.

Bhoomi Viswanad1, Krishnamoorthy Srinivasan, Chaman Lal Kaul, Poduri Ramarao.   

Abstract

The altered vascular responses to various vasopressors and relaxants have been well reported in various animal models of hypertension, insulin resistance and diabetes. Though the role of oxidative stress (increased superoxide levels) associated with these altered vascular responses in hyperglycemic/diabetic state is well documented, the role of the same remains to be largely unknown in vascular dysfunction coupled with prediabetic insulin resistant state. The objective of the present study was therefore to elucidate the role of free radicals particularly superoxides if any associated with vascular dysfunction in diet-induced insulin resistance of rats. In this regard, the effect of tempol (a membrane permeable superoxide dismutase mimetic/free radical scavenger) on the enhanced Ang II-induced contraction and impaired-ACh mediated relaxation in thoracic aorta of rats with insulin resistance was studied. Ang II-induced contraction and ACh-mediated relaxation responses were recorded isometrically in endothelium intact and denuded thoracic aortic ring preparations isolated from male Sprague-Dawley rats which were fed with either normal pellet diet (NPD) (control group) or high fat diet (HFD) (insulin resistant group) for 4 weeks. The HFD-fed rats exhibited characteristic features of insulin resistance syndrome viz., obesity, hyperinsulinaemia, mild hyperglycemia, hypertriglyceridemia, hypercholesterolemia, glucose intolerance and hypertension. Maximal contractile response (E(max)) to Ang II was increased in endothelium intact aortic ring preparations obtained from HFD-fed rats as compared to NPD-fed control rats. Denudation of endothelium significantly increased Ang II-mediated E(max) responses in thoracic aortic rings of NPD-fed rats, whereas it produced only minimal alteration to the E(max) in the HFD-fed rats. In addition, ACh-mediated relaxation response was impaired in endothelium intact aortic rings isolated from HFD-fed rats. Tempol (30-300 microM) significantly and dose dependently inhibited enhanced vascular responses (E(max)) of Ang II in endothelium intact, but not in endothelium denuded aortic ring preparations. Tempol (30 microM) reversed the impaired acetylcholine (ACh)-mediated relaxations in endothelium intact aortic ring preparations of HFD-fed rats. Endothelium independent vasorelaxations (EIV) to sodium nitroprusside (SNP) were similar for both NPD and HFD. In conclusion, our results indicate that superoxide radicals play crucial role in enhanced contractile and impaired vasodilatory responses to Ang II and ACh, respectively, in thoracic aortic rings isolated from diet-induced insulin resistant rats.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16412660     DOI: 10.1016/j.phrs.2005.11.002

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  18 in total

1.  The effect of losartan and carvedilol on renal haemodynamics and altered metabolism in fructose-fed Sprague-Dawley rats.

Authors:  Mohammed H Abdulla; Munavvar A Sattar; Nor A Abdullah; Edward J Johns
Journal:  J Physiol Biochem       Date:  2012-01-27       Impact factor: 4.158

2.  High fat feeding impairs endothelin-1 mediated vasoconstriction through increased iNOS-derived nitric oxide.

Authors:  K L Sweazea; B R Walker
Journal:  Horm Metab Res       Date:  2011-03-29       Impact factor: 2.936

3.  Pentoxifylline alleviates vascular impairment in insulin resistance via TNF-α inhibition.

Authors:  Hany M El-Bassossy; Mohamed A El-Moselhy; Mona F Mahmoud
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-07-29       Impact factor: 3.000

4.  Caveolin-1 prevents sustained angiotensin II-induced resistance artery constriction and obesity-induced high blood pressure.

Authors:  Istvan Czikora; Attila Feher; Rudolf Lucas; David J R Fulton; Zsolt Bagi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-19       Impact factor: 4.733

5.  17-β Oestradiol prevents cardiovascular dysfunction in post-menopausal metabolic syndrome by affecting SIRT1/AMPK/H3 acetylation.

Authors:  Dhaval Sharad Bendale; Pinakin Arun Karpe; Richa Chhabra; Sachin Prabhakarrao Shete; Heta Shah; Kulbhushan Tikoo
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

6.  High-fructose diet is as detrimental as high-fat diet in the induction of insulin resistance and diabetes mediated by hepatic/pancreatic endoplasmic reticulum (ER) stress.

Authors:  M Balakumar; L Raji; D Prabhu; C Sathishkumar; P Prabu; V Mohan; M Balasubramanyam
Journal:  Mol Cell Biochem       Date:  2016-10-03       Impact factor: 3.396

7.  Prolonged treatment with angiotensin 1-7 improves endothelial function in diet-induced obesity.

Authors:  Andreas M Beyer; Deng-Fu Guo; Kamal Rahmouni
Journal:  J Hypertens       Date:  2013-04       Impact factor: 4.844

8.  Comparison of mechanisms involved in impaired vascular reactivity between high sucrose and high fat diets in rats.

Authors:  Karen L Sweazea; Mateja Lekic; Benjimen R Walker
Journal:  Nutr Metab (Lond)       Date:  2010-06-04       Impact factor: 4.169

9.  Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol.

Authors:  Paras K Mishra; Neetu Tyagi; Utpal Sen; Irving G Joshua; Suresh C Tyagi
Journal:  Cardiovasc Diabetol       Date:  2010-09-09       Impact factor: 9.951

10.  Effects of angiotensin II AT₁-receptor blockade on high fat diet-induced vascular oxidative stress and endothelial dysfunction in Dahl salt-sensitive rats.

Authors:  Shinji Kosaka; Nicolas Pelisch; Matlubur Rahman; Daisuke Nakano; Hirofumi Hitomi; Hiroyuki Kobori; Noriyasu Fukuoka; Hideki Kobara; Hirohito Mori; Tsutomu Masaki; Ludek Cervenka; Yasuo Matsumura; Hitoshi Houchi; Akira Nishiyama
Journal:  J Pharmacol Sci       Date:  2013-01-22       Impact factor: 3.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.